These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 9471457)

  • 1. [Screening for trisomy 21 using biological markers and ultrasonography].
    Rozenberg P; Philippe HJ; Perdu M; Nisand I
    J Gynecol Obstet Biol Reprod (Paris); 1997; 26(3 Suppl):187-9. PubMed ID: 9471457
    [No Abstract]   [Full Text] [Related]  

  • 2. [Trisomy 21 screening: value of ultrasound and serum markers in a combined approach].
    Senat MV; Rozenberg P; Bernard JP; Ville Y
    J Gynecol Obstet Biol Reprod (Paris); 2001 Feb; 30(1):11-27. PubMed ID: 11240502
    [No Abstract]   [Full Text] [Related]  

  • 3. [Screening by maternal serum markers for Down's syndrome].
    Liu JT; Hao N; Sun NH; Wang FY; Xu YH; Gai MY; Bian XM; Yang JQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):156-9. PubMed ID: 12905710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The variation of risk estimates through pregnancy in second trimester maternal serum screening for Down syndrome.
    Christiansen M; Høgdall EV; Larsen SO; Høgdall C
    Prenat Diagn; 2002 May; 22(5):385-7. PubMed ID: 12001192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down syndrome: prenatal risk assessment and diagnosis.
    Newberger DS
    Am Fam Physician; 2000 Aug; 62(4):825-32, 837-8. PubMed ID: 10969860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. hCG and the free beta-subunit as screening tests for Down syndrome.
    Knight GJ; Palomaki GE; Neveux LM; Fodor KK; Haddow JE
    Prenat Diagn; 1998 Mar; 18(3):235-45. PubMed ID: 9556040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second-trimester maternal serum screening for Down syndrome in Mainland China.
    Liao C; Huang Y; Li D; Song S; Yi C; Zhou J
    Prenat Diagn; 2006 Dec; 26(13):1271-2. PubMed ID: 17139699
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of effect of analytical imprecision in maternal serum screening for Down's syndrome.
    Spencer K
    Ann Clin Biochem; 2001 Jul; 38(Pt 4):413-4. PubMed ID: 11471889
    [No Abstract]   [Full Text] [Related]  

  • 9. Second-trimester maternal serum screening for Down syndrome in twin-to-twin transfusion syndrome.
    Sermondade N; Dreux S; Oury JF; Muller F
    Prenat Diagn; 2009 Aug; 29(8):814-5. PubMed ID: 19418465
    [No Abstract]   [Full Text] [Related]  

  • 10. Screening for trisomy 18 by maternal age, fetal nuchal translucency, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
    Kagan KO; Wright D; Maiz N; Pandeva I; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Sep; 32(4):488-92. PubMed ID: 18726925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second trimester two-step trisomy 18 screening using maternal serum markers.
    Muller F; Sault C; Lemay C; Roussel-Mizon N; Forestier F; Frendo JL;
    Prenat Diagn; 2002 Jul; 22(7):605-8. PubMed ID: 12124697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antenatal screening for Down syndrome: a smattering of epidemiology].
    Boulvain M; Billieux MH; Irion O
    Rev Med Suisse; 2008 Oct; 4(176):2276-8, 2280. PubMed ID: 19025178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First- and second-trimester screening: detection of aneuploidies other than Down syndrome.
    Breathnach FM; Malone FD; Lambert-Messerlian G; Cuckle HS; Porter TF; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Klugman S; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Tripp T; Bianchi DW; D'Alton ME;
    Obstet Gynecol; 2007 Sep; 110(3):651-7. PubMed ID: 17766613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The prenatal detection of trisomy 13, 18, and 21: comparison of the advanced first trimester screening (AFS) with the first trimester screening according to Nicolaides].
    Hörmansdörfer C; Schmidt P; Hillemanns P; Scharf A
    Z Geburtshilfe Neonatol; 2007 Dec; 211(6):243-9. PubMed ID: 18176905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Second trimester Down syndrome serum screening--results from a pilot study].
    Dimitrova V; Chernev T; Kremenski I; Mazneĭkova V; Mikhaĭlova E; Simeonov E; Tincheva R; Toncheva D
    Akush Ginekol (Sofiia); 2002; 41(2):3-12. PubMed ID: 12066548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical screenings in twin medically treated pregnancies: assessment of trisomy and prothrombotic risk.
    Donato M; Borin E; Bevacqua G; D'Ottavio G; Parco S
    Minerva Ginecol; 2008 Jun; 60(3):263-4. PubMed ID: 18547989
    [No Abstract]   [Full Text] [Related]  

  • 17. First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics.
    Kagan KO; Wright D; Spencer K; Molina FS; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 May; 31(5):493-502. PubMed ID: 18432600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First trimester markers of trisomy 21 and the influence of maternal cigarette smoking status.
    Spencer K; Ong CY; Liao AW; Papademetriou D; Nicolaides KH
    Prenat Diagn; 2000 Oct; 20(10):852-3. PubMed ID: 11038470
    [No Abstract]   [Full Text] [Related]  

  • 19. False-positive quadruple screen test for trisomy 18 in a patient with a fetus with Bloom's syndrome.
    Baxi L; Brown S; Thaker HM
    Fetal Diagn Ther; 2007; 22(4):318-20. PubMed ID: 17361088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thoughts about screening for Down syndrome].
    Gardó S
    Orv Hetil; 2009 Mar; 150(11):497-501; discussion 501-2. PubMed ID: 19258245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.